Evolus (EOLS) Competitor Comparison
We are evaluating the key criteria listed to compare Evolus (EOLS) against its competitors in the Drug Manufacturers - Specialty & Generic industry.
Market Capitalization
23 / 54Gross Profits
24 / 39Total Revenue
29 / 50EBITDA
46 / 53Free Cashflow
42 / 54Quick Ratio
28 / 54Earnings per Share
38 / 54Dividend yield
0 / 5Total Cash
38 / 54Performance 3 years
4 / 54Performance 5 years
17 / 54Performance 10 years
16 / 54Linearity 3 years
14 / 54Linearity 5 years
5 / 54Linearity 10 years
3 / 54Total Rank
36 / 54Dividend Rank
18 / 54Valuation Rank
33 / 54Piotroski Rank
49 / 54Muliplier Rank
41 / 54Market Capitalization - EOLS ranking 23 / 54
Obligatory risk notice
We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.